/Verisk%20Analytics%20Inc%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
New Jersey-based Verisk Analytics, Inc. (VRSK) engages in the provision of data analytics and technology solutions to the insurance industry in the United States and internationally. With a market cap of $43.7 billion, the company reports through three business segments: Insurance, Energy and Specialized Markets, and Financial Services.
Companies worth $10 billion or more are generally described as "large-cap stocks." CTVA falls squarely into this category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the Consulting Services industry. The company benefits from being the largest bank account consortium to offer competitive benchmarking, decision-making algorithms, business intelligence, and customized analytic services to financial institutions.
Shares of the company touched their 52-week high of $322.92 on Jun. 5 and have fallen 3.5% from that peak. Shares of VRSK have surged 7.2% over the past three months, underperforming the Industrial Select Sector SPDR Fund’s (XLI) 10.9% growth over the same time frame.
Longer term, VRSK stock is up 13.1% on a YTD basis, outperforming XLI’s 9.5% rise. However, shares of the company have surged 17.7% over the past 52 weeks, compared to XLB’s 18.2% rally over the same time frame.
To confirm its bullish trend, VRSK has been trading above its 200-day moving average since last year and above its 50-day moving average since late April.
On May 7, VRSK shares closed up more than 4% following the release of its Q1 results. The company’s revenue came in at $753 million, beating Wall Street forecasts of $750 million. Moreover, its adjusted EPS of $1.73 exceeded Wall Street expectations by 3.6%. VRSK expects full-year adjusted EPS in the range of $6.80 to $7.10, and expects revenue in the range of $3 billion to $3.1 billion.
Its peer, Equifax Inc. (EFX), has slightly underperformed the stock over the past year, with its shares growing 6.5% in 2025 and 17.8% in the past 52 weeks.
Among the 19 analysts covering the VRSK stock, the consensus rating is a “Moderate Buy.” Its mean price target of $316.65 suggests a 1.7% upside potential from current price levels.
